Skip to main content

We make finding a doctor in the UAE free, transparent, and easy.

Back to Intelligence
4 checks Dubai patients should make as Abu Dhabi takes prevention AI to New York

4 checks Dubai patients should make as Abu Dhabi takes prevention AI to New York

Abu Dhabi’s prevention AI push will not change your next bill overnight. Dubai patients should check data access, coverage and clinical review.

Zavis Intelligence·Healthcare Industry Desk
27 Sept 2026·3 min read

How Zavis verifies this coverage

Editorial standards, source rules, methodology, and review provenance are public.

For a patient in Dubai, Abu Dhabi’s disease-prevention and AI push in New York means one practical thing first: ask your clinic how your records, insurer approval and doctor review will work before you pay for a preventive test.

The news peg is international. Future Health, a global initiative by Abu Dhabi, convened ministers and health leaders from 15 countries in New York during UNGA 81, according to a Future Health statement. The patient impact in the UAE is local. In Dubai, the relevant regulator is the Dubai Health Authority (DHA). In Abu Dhabi, it is the Department of Health Abu Dhabi (DOH). In the northern emirates, the relevant federal authority is the Ministry of Health and Prevention (MOHAP).

What changes for a Dubai patient

The short answer is speed and scrutiny. AI-linked prevention programmes usually depend on three inputs: medical history, laboratory results and imaging. In Dubai, the operating question is whether the provider is connected to NABIDH, DHA’s health information exchange for medical records across public and private facilities. NABIDH’s public site was last updated on 1 September 2026 and describes the system as a secure exchange for trusted health information in Dubai.

A patient booking a cardiac, diabetes, cancer-risk or longevity assessment should ask four questions before payment:

  • Is the clinic licensed by DHA, and is the doctor named on the appointment also licensed?
  • Will the clinic use NABIDH records, or will it rely only on new tests ordered that day?
  • Will Daman, Thiqa, Sukoon or another insurer treat the visit as covered care, screening or cash-pay wellness?
  • Who signs the final report if an AI tool flags a risk: a consultant, specialist or general practitioner?

That last question matters. A risk score is not a diagnosis. The UAE licensing and complaints route still runs through the regulator for the emirate where care is delivered. For a Dubai clinic, that is DHA. For an Abu Dhabi hospital, that is DOH. For Sharjah, Ajman, Umm Al Quwain, Ras Al Khaimah and Fujairah, it is MOHAP or the relevant local public provider route.

Coverage will decide adoption

Patients should expect uneven coverage at first. UAE insurers usually distinguish between medically indicated tests and elective screening. A doctor-ordered HbA1c for suspected diabetes, lipid profile for cardiovascular risk, or follow-up imaging after abnormal symptoms is more likely to enter a normal claims pathway than a broad wellness panel bought as a package.

Do not rely on a brochure price. Ask the clinic for the service code, the physician specialty, the laboratory name and whether pre-authorisation is required before the sample is taken. If the provider cannot give those details, ask your insurer directly through the member app or call centre. The useful number is your confirmed co-pay or excluded amount in AED, not the headline package price.

Abu Dhabi is further ahead on population-linked infrastructure. DOH says Malaffi, launched in 2019, connects more than 2,700 facilities in Abu Dhabi. DOH’s 2026 health information exchange standards also require providers to monitor current technical specifications and timelines for data transmitted to Malaffi. That matters for Dubai residents who seek care in Abu Dhabi, because their records may sit across systems.

What to watch next

The clearest patient benefit would be fewer repeated tests and earlier referral for high-risk cases. MOHAP said on 7 December 2021 that Riayati, the national unified medical record, links with DHA’s NABIDH and Emirates Health Services’ Wareed. DOH also says Malaffi is integrated with Riayati and NABIDH. The test for patients is whether that integration appears at the counter, during the consultation and in the discharge report.

There are limits. AI prevention tools can produce false positives, false reassurance and more cash-pay testing. Patients should ask whether the tool has local validation for UAE populations, whether the report names the clinician responsible, and whether the recommendation changes treatment today. If the answer is a vague wellness plan, treat it as consumer health advice until a licensed UAE doctor documents a clinical reason.

For Dubai patients, the best immediate action is basic due diligence: verify the clinic licence, confirm insurer coverage, ask how records will be accessed, and keep a copy of the signed report. To find licensed clinics and providers in the UAE, start with the UAE Open Healthcare Directory.

ZI

Zavis Intelligence

Healthcare Industry Desk

Contributing to UAE healthcare industry coverage

Source: thenationalnews.com

FAQ

What is happening in UAE healthcare industry?

Abu Dhabi’s prevention AI push will not change your next bill overnight. Dubai patients should check data access, coverage and clinical review.